ロード中...
How do we sequence therapy for marginal zone lymphomas?
Marginal zone lymphomas are indolent diseases. Overall survival rates are very good, but patients tend to relapse and may do so several times. The concept of treatment sequencing is therefore important and necessary to preserve adequate organ function and to avoid excessive toxicity, with the final...
保存先:
| 出版年: | Hematology Am Soc Hematol Educ Program |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7727586/ https://ncbi.nlm.nih.gov/pubmed/33275704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2020000157 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|